Lilly (Eli)

LLY · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

1.198%

12M weight contribution

+0.421 pp

3M weight contribution

+0.280 pp

12M price return

+43.3%

Share of matched S&P 500 members

Monthly observations through Jun 2022

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Jun 2022	$308.1bn	1.198%	+0.421 pp	+43.3%	Yes
May 2022	$297.8bn	1.073%	+0.386 pp	+59.1%	Yes
Apr 2022	$277.6bn	1.004%	+0.368 pp	+62.3%	Yes
Mar 2022	$272.7bn	0.918%	+0.568 pp	+55.6%	Yes
Feb 2022	$238.0bn	0.826%	+0.433 pp	+23.8%	Yes
Jan 2022	$234.7bn	0.789%	+0.313 pp	+19.8%	No
Dec 2021	$264.2bn	0.846%	+0.193 pp	+66.1%	Yes
Nov 2021	$237.3bn	0.802%	+0.210 pp	+72.9%	Yes
Oct 2021	$243.7bn	0.814%	+0.223 pp	+98.6%	Yes
Sep 2021	$221.0bn	0.776%	+0.775 pp	+58.8%	Yes
Aug 2021	$247.1bn	0.826%	+0.825 pp	+77.0%	Yes
Jul 2021	$233.5bn	0.801%	+0.800 pp	+65.1%	Yes
Jun 2021	$220.1bn	0.777%	+0.776 pp	+42.4%	Yes
May 2021	$191.6bn	0.686%	+0.685 pp	+33.0%	Yes
Apr 2021	$175.3bn	0.635%	-0.192 pp	+20.4%	Yes
Mar 2021	$179.1bn	0.350%	+0.349 pp	+37.2%	No
Feb 2021	$196.4bn	0.392%	+0.392 pp	+65.5%	No
Jan 2021	$198.9bn	0.476%	-0.185 pp	+51.9%	Yes
Dec 2020	$161.5bn	0.654%	+0.035 pp	+31.0%	Yes
Nov 2020	$139.3bn	0.592%	+0.024 pp	+26.6%	Yes
Oct 2020	$124.8bn	0.591%	+0.021 pp	+16.9%	Yes
Sep 2020	$141.6bn	0.001%	-0.573 pp	+35.1%	No
Aug 2020	$141.9bn	0.001%	-0.592 pp	+34.1%	No
Jul 2020	$143.7bn	0.001%	-0.562 pp	+40.9%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.